Autism treatment market size to surpass US$13.14 billion by 2030

Pune, India – Autism spectrum disorder treatment market size to reach US$6.94 billion in 2022, and projected to grow US$7.41 billion in 2023 To US$13.14 billion by 2030 Exhibit A CAGR of 8.5% In the estimated period.

Increased awareness of autism, particularly among health care professionals, parents, and the public, has made diagnosis possible earlier. Early detection allows for better intervention and treatment, thereby increasing the demand for autism-related treatments, services and medicines, thereby fueling market growth.

Fortune Business Insights™ provides this information in its research report titled “Autism Spectrum Disorder Treatment Market, 2023-2030.”

Major Industry Developments:

Behavioral Innovations introduced a new range of comprehensive autism assessment services for children. The aim of this launch was to enable early diagnosis and intervention for children with ASD.

key takeaways:

The increasing prevalence of ASD is driving the growth of the ASD treatment market, increasing demand for effective treatments, and technological advancements in ASD diagnosis and therapy.

The ASD treatment market is segmented by therapeutic approach, application, and end-user.

Major players in the ASD treatment market are Novartis AG, Johnson & Johnson, Shire Pharmaceuticals Ltd., Eli Lilly & Company, and Roche.

These companies are investing in research and development, new product development and mergers and acquisitions to maintain their competitive edge in the market.

The ASD treatment market is facing some challenges, such as lack of treatment for ASD, limited efficacy of current treatments, and high cost of treatment.

Source:  BusinessNews